Obesity Clinical Trial
Official title:
Pilot Meal Replacement-Based Diet Effectiveness Study
Adolescent obesity is associated with a number of serious health conditions and most obese
adolescents become obese adults. Despite this fact, very few adolescent health centers offer
clinical weight loss programs. This is likely because most weight loss programs require
extensive resources and are not covered by most health insurance policies. However, this is
expected to change since the American Medical Association's recent decision to recognize
obesity as a disease. Therefore, it is important to identify simple and effective
nonsurgical programs for weight loss, which can be used in adolescent health centers. The
investigators are proposing to show that a meal replacement based diet program will be
effective in reducing body mass index (weight adjusted for height). In this pilot study, 90
adolescents will either participate in a meal replacement based weight loss program or watch
an educational video. Body mass index and body fat will be recorded over time to see if
adolescents participating in the meal replacement program lose more weight than those who do
not participate in this program.
In order to address this objective, the investigators will assess group differences in body
mass index (BMI; kg/m2), body composition (% body fat), eating disorder symptoms and
psychological/behavioral variables.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 24 Years |
Eligibility |
Inclusion Criteria: - Patient at Mount Sinai Adolescent Health Center - 18-24 years old - Obese (BMI at or above the 95th percentile for patients = 20 y.o and BMI = 30 for patients =21 y.o.) Exclusion Criteria: - Not a patient at Mount Sinai Adolescent Health Center - Current eating disorder (anorexia nervosa, bulimia nervosa or binge eating disorder) - Girls who are pregnant or planning to become pregnant. A participant who becomes pregnant during the study will be terminated from the study. - Patients with diabetes - Individuals with active psychiatric or substance use disorders - Individuals who are allergic to tree nuts, peanuts, milk, eggs, wheat, and sesame. - Normal weight or overweight patients (< 95th percentile) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Icahn School of Medicine at Mount Sinai |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Mass Index (BMI) | - Body mass index (BMI; kg/m2). Height will be measured to the nearest millimeter using a direct reading stadiometer. Weight will be assessed to the nearest 0.1 kg using a digital scale (Tanita TBF-300A) with participants wearing light clothing without shoes or coats. | up to 12 months | No |
Secondary | Body Fat as measured by Bioelectrical impedance analysis (BIA) | Bioelectrical impedance analysis (BIA) using the Tanita TBF-300A Body Composition Analyzer to assess % body fat to maximize sensitivity to predict increases in body fat and obesity onset. | up to 12 months | No |
Secondary | Eating Disorder symptoms as measured by the Eating Disorder Diagnostic Scale | The Eating Disorder Diagnostic Scale for screening eating pathology | up to 12 months | No |
Secondary | Body Dissatisfaction as measured by an adapted form of the Satisfaction and Dissatisfaction with Body Parts Scale | an adapted form of the Satisfaction and Dissatisfaction with Body Parts Scale to assess body satisfaction. It asks respondents to rate their level of satisfaction with nine body parts on 6-point scales ranging from "extremely satisfied" to "extremely dissatisfied." | up to 12 months | No |
Secondary | Depressive symptoms as measured by the 21-item Beck Depression Inventory | The 21-item Beck Depression Inventory to assess depressive symptoms | up to 12 months | No |
Secondary | Emotional Eating as measured by the Emotional Eating scale | The Emotional Eating scale from the Dutch Eating Behavior Questionnaire | up to 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |